GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CELLUMED Co Ltd (XKRX:049180) » Definitions » PB Ratio

CELLUMED Co (XKRX:049180) PB Ratio : 2.26 (As of Jun. 24, 2024)


View and export this data going back to 2002. Start your Free Trial

What is CELLUMED Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-24), CELLUMED Co's share price is ₩1448.00. CELLUMED Co's Book Value per Share for the quarter that ended in Mar. 2024 was ₩640.19. Hence, CELLUMED Co's PB Ratio of today is 2.26.

The historical rank and industry rank for CELLUMED Co's PB Ratio or its related term are showing as below:

XKRX:049180' s PB Ratio Range Over the Past 10 Years
Min: 1.06   Med: 4.07   Max: 35.17
Current: 2.26

During the past 13 years, CELLUMED Co's highest PB Ratio was 35.17. The lowest was 1.06. And the median was 4.07.

XKRX:049180's PB Ratio is ranked worse than
51.02% of 784 companies
in the Medical Devices & Instruments industry
Industry Median: 2.205 vs XKRX:049180: 2.26

During the past 12 months, CELLUMED Co's average Book Value Per Share Growth Rate was -46.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -12.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 3.90% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -16.70% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of CELLUMED Co was 82.40% per year. The lowest was -63.60% per year. And the median was -16.70% per year.

Back to Basics: PB Ratio


CELLUMED Co PB Ratio Historical Data

The historical data trend for CELLUMED Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CELLUMED Co PB Ratio Chart

CELLUMED Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.08 7.54 5.53 3.40 4.10

CELLUMED Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.48 3.86 3.05 4.10 2.80

Competitive Comparison of CELLUMED Co's PB Ratio

For the Medical Instruments & Supplies subindustry, CELLUMED Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CELLUMED Co's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CELLUMED Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where CELLUMED Co's PB Ratio falls into.



CELLUMED Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

CELLUMED Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=1448.00/640.188
=2.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


CELLUMED Co  (XKRX:049180) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


CELLUMED Co PB Ratio Related Terms

Thank you for viewing the detailed overview of CELLUMED Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CELLUMED Co (XKRX:049180) Business Description

Traded in Other Exchanges
N/A
Address
Acetechno Tower 9 402, Gasan-dong, Geumcheon-gu, Seoul, KOR, 153-782
CELLUMED Co Ltd is a Korean company which is engaged in manufacturing and sale of medical equipment and biosimilars. Its products portfolio includes allografts for tissue repair, bone sponges, bone powders and demineralized bone matrixes (DBMs) for bone regeneration and biosimilars such as bone morphogenetic protein 2 (BMP2) reagents and others. It also produces medical devices, such as spinal fixation systems, joint replacements, and navigation systems.

CELLUMED Co (XKRX:049180) Headlines

No Headlines